TMS in general is a safe* alternative therapy for patients who do not benefit from or tolerate other treatment options. TMS is accepted as an evidence-based treatment option by the American Psychiatric Association (APA), the Canadian Network for Mood and Anxiety Treatments (CANMAT), and the World Federation of Societies of Biological Psychiatry (WFSBP).
TMS treatment has been approved by FDA since 2008 for patients with depression who have failed to archieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.
Controlled clinical studies** applying TMS on patients for major depression showed that:
Approximately 1 out of 2 patients experienced significant improvement in depression symptoms.
Approximately 1 out of 3 patients experienced complete symptom relief after the full TMS therapy.
**Carpenter LL et al. (2012) Transcranial Magnetic Stimulation (TMS) for Major Depression: a Multisite, Naturalistic, Observational Study of Acute Treatment Outcomes in Clinical Practice.Depression and Anxiety, 29(7):587-596.
www.ncbi.nlm.nih.gov/pubmed/22689344